Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
43.18
-0.38 (-0.87%)
Aug 13, 2026, 4:00 PM EDT - Market closed
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $4.69 billion as of August 14, 2026. Its market cap has increased by 232.45% in one year.
Market Cap
4.69B
Enterprise Value
4.23B
1-Year Change
232.45%
Ranking
Category
Stock Price
$43.18
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $4.69B, an increase of 516.17%. That is a compound annual growth rate of 40.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 4.69B | 78.50% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 5.68B |
| Definium Therapeutics | 5.50B |
| CRISPR Therapeutics AG | 5.23B |
| ACADIA Pharmaceuticals | 5.07B |
| Dyne Therapeutics | 4.99B |
| Parabilis Medicines | 4.64B |
| Veradermics | 4.55B |
| Relay Therapeutics | 4.38B |